Sam J.L. van der Tuin

Exendin‐4 decreases liver inflammation and atherosclerosis development simultaneously by reducing macrophage infiltration

Yanan Wang, Edwin T. Parlevliet, Janine J. Geerling et al. · British Journal of Pharmacology · 2013 · 118 citations · Full text

Lipopolysaccharide Lowers Cholesteryl Ester Transfer Protein by Activating F4/80 ⁺ Clec4f ⁺ Vsig4 ⁺ Ly6C ⁻ Kupffer Cell Subsets

Sam J.L. van der Tuin, Li Zhuang, Jimmy F.P. Berbée et al. · Journal of the American Heart Association · 2018 · 81 citations · Full text

Anacetrapib reduces progression of atherosclerosis, mainly by reducing non-HDL-cholesterol, improves lesion stability and adds to the beneficial effects of atorvastatin

Susan Kühnast, Sam J.L. van der Tuin, José W.A. van der Hoorn et al. · European Heart Journal · 2014 · 73 citations · Full text

Anacetrapib reduces (V)LDL cholesterol by inhibition of CETP activity and reduction of plasma PCSK9

Sam J.L. van der Tuin, Susan Kühnast, Jimmy F.P. Berbée et al. · Journal of Lipid Research · 2015 · 32 citations · Full text